The acquisition will strengthen Charles River's position as a global early-stage CRO, expanding its client base and service portfolio. Source: BioSpace

Bob Hugin announced his campaign on Monday in an email. Source: BioSpace

The Branford, CT-based company was founded in 2017 and plans to list on the Nasdaq under the symbol BTAI. Source: BioSpace

Amicus announced that the FDA accepted its NDA for migalastat to treat Fabry disease in patients with amenable mutations. Source: BioSpace

With the deal in hand, Roivant has stepped into the world of metabolic diseases. Source: BioSpace

The fast-growing company will anchor 399 Binney St., an Alexandria Real Estate Equities property. Source: BioSpace

Mr. Goater succeeds interim chief executive officer Dan Lynch, who will remain executive chairman of Surface’s board of directors. Source: BioSpace

The study assessed two doses of RG7716 versus ranibizumab standard of care given as monthly intravitreal injections. Source: BioSpace

Axovant shares plunged after Hung abruptly resigned as CEO and also stepped down from his seat on the company board of directors. Source: BioSpace

A look at three drug approvals of vital importance to the company this year. Source: BioSpace